Skip to main content
Livermore
Livermore
ZHEN

Metlife Inc

SEC CIK
0001099219
Latest filing
Aug 13, 2026

The latest 13F from Metlife Inc covers Q2 2026 (filed Aug 13, 2026): 6 long positions worth $13.1M. The top 10 holdings make up 100.0% of the portfolio, and the largest is SPDR S&P 500 ETF Trust (SPY) at 39.2%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
0
Reduced
0
Sold out
0

Top 5 holdings

Share of this quarter's portfolio value

  1. SPYSPDR S&P 500 ETF Trust
    39.2%$5.14MHistory
  2. iShares Inc464286640
    26.2%$3.43M
  3. iShares Tr464287390
    18.5%$2.42M
  4. iShares Inc46434G822
    7.3%$950.4K
  5. iShares Tr464287861
    5.3%$692.0K

Biggest buys

New and added positions, by estimated amount bought

None this quarter.

Largest weight increases

New and added positions, by percentage points of the portfolio gained

None this quarter.

Biggest sells

Reduced and sold-out positions, by estimated amount sold

None this quarter.

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

None this quarter.

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$13.1M
+$753.5K (+6.1%) vs. prior quarter
Positions
6
0 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
0.0%
Q2 2026, one quarter
Average holding period
22.0 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $13.1M (Q2 2026)

Q1 2021: $11.9MQ2 2021: $12.6MQ3 2021: $11.5MQ4 2021: $11.0MQ1 2022: $12.1MQ2 2022: $9.79MQ3 2022: $9.23MQ4 2022: $9.56MQ1 2023: $10.1MQ2 2023: $10.5MQ3 2023: $9.81MQ4 2023: $10.6MQ1 2024: $10.8MQ2 2024: $10.4MQ3 2024: $10.0MQ4 2024: $9.34MQ1 2025: $9.68MQ2 2025: $10.4MQ3 2025: $11.1MQ4 2025: $12.2MQ1 2026: $12.3MQ2 2026: $13.1M
Q1 2021Q2 2026
13F filings of Metlife Inc by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 13, 20266$13.1MSPYiShares InciShares Trvs. Q1 2026SEC
Q1 2026May 14, 20266$12.3MSPYiShares InciShares Trvs. Q4 2025SEC
Q4 2025Feb 12, 20266$12.2MSPYiShares InciShares Trvs. Q3 2025SEC
Q3 2025Nov 13, 20256$11.1MSPYiShares InciShares Trvs. Q2 2025SEC
Q2 2025Aug 13, 20256$10.4MSPYiShares InciShares Trvs. Q1 2025SEC
Q1 2025May 14, 20256$9.68MSPYiShares InciShares Trvs. Q4 2024SEC
Q4 2024Feb 13, 20256$9.34MSPYiShares InciShares Trvs. Q3 2024SEC
Q3 2024Nov 13, 20246$10.0MSPYiShares InciShares Trvs. Q2 2024SEC
Q2 2024Aug 13, 20246$10.4MSPYiShares InciShares Trvs. Q1 2024SEC
Q1 2024May 14, 20246$10.8MSPYiShares InciShares Trvs. Q4 2023SEC
Q4 2023Feb 14, 20246$10.6MSPYiShares InciShares Trvs. Q3 2023SEC
Q3 2023Nov 14, 20236$9.81MSPYiShares InciShares Trvs. Q2 2023SEC
Q2 2023Aug 10, 20236$10.5MSPYiShares InciShares Trvs. Q1 2023SEC
Q1 2023May 15, 20236$10.1MSPYiShares InciShares Trvs. Q4 2022SEC
Q4 2022Mar 23, 2023Amended6$9.56MSPYiShares InciShares Trvs. Q3 2022SEC
Q3 2022Mar 23, 20236$9.23MSPYiShares InciShares Trvs. Q2 2022SEC
Q2 2022Mar 23, 20236$9.79MSPYiShares InciShares Trvs. Q1 2022SEC
Q1 2022Mar 23, 20236$12.1MSPYiShares InciShares Trvs. Q4 2021SEC
Q4 2021Mar 23, 20236$11.0MSPYiShares TriShares Incvs. Q3 2021SEC
Q3 2021Mar 23, 20236$11.5MSPYiShares InciShares Trvs. Q2 2021SEC
Q2 2021Mar 23, 20236$12.6MSPYiShares TriShares Incvs. Q1 2021SEC
Q1 2021Mar 23, 20236$11.9MSPYiShares InciShares Tr–SEC